China's Zhongke Ion raises $89.5M for fusion tech commercialisation
What's the deal? Zhongke IonDealroom has a profile for this one. Try Dealroom →, a Chinese company commercialising nuclear fusion technology, has raised roughly US$82.5M in its first market-based equity round. The early-stage round drew a group of established investors.
Who's backing it? Wanneng Capital co-invested alongside CMB InternationalDealroom has a profile for this one. Try Dealroom →, Qianhai Ark, China Securities Capital, SMIC Capital, and Hua'an Jiaye, among others.
What's the endgame? Zhongke Ion is working to turn fusion research results into commercial technology, one of the hardest problems in energy. This first external round marks its shift from lab-stage work toward market-driven development.
The signal: The round reflects rising investor appetite for fusion in China, with state-linked and financial backers betting early on a technology still years from the grid.
Read more: sohu.com
Image credit: Culham Centre for Fusion Energy.
